Signum dermalogix, a spin out of signum biosciences is a private biotech company founded in 2011 from technologies developed by dr. Gregory stock who will continue to remain active with the company as a member of the board. Stock serves on the california advisory committee on stem cells and reproductive cloning, and on the board of directors of signum biosciences, nutralogix, and napo pharmaceuticals. Braham shroot, formerly cso of barrier therapeutics, as chief executive officer. Gregory stock is a leading authority on the broad impacts of genomic and other advanced technologies in the life sciences. Gregory stock, a biotech entrepreneur, bioethicist, bestselling author and public communicator is a leading authority on the broad impacts of. Stock, a humbolt prize winner who is a globally recognized leader in the genetics and biochemistry of cellular signaling and chemotaxis. Keynote speaker gregory stock is a strong advocate for aggressive biomedical funding and research, and for cautious governmental oversight. Gregory stock, stock s brother, served as the first ceo in 2008 signum partnered with rohto pharmaceutical co. Stock is now primarily engaged in the development of new therapeutics at signum biosciences, a biotech company he cofounded in 2004, but he remains active in the policy arena through uclas mts program, which he still directs, and the bioagenda institute, which he is the associate director of, and through various public appearances and debates. What are we really afraid of signum biosciences ucla center for society and genetics napo pharmaceuticals gregory stock on pbs gregory stock on charlie rose alliance for aging research the bioagenda institute engineering the human. Signum biosciences ceo and president, maxwell stock, has dedicated his life to translational scientific research and sciencebased product development.
Gregory b stock a method of determining particle size distributions in lipid vesicle preparations is outlined. In 2003, he cofounded signum biosciences, a princeton university spinoff created. In 2004, stock cofounded signum biosciences, a princeton university spinoff created to develop a new class of antiinflammatories and therapeutics for neurodegeneration. Signum biosciences is a private biotechnology company dedicated to acquiring and developing effective, innovative, economical medicines to. Speaker gregory stock heath care and biotech keynotes. A vesicle suspension is modeled as a polydisperse mixture of spherical shells. Stock, a professor at princeton university, on compounds that can modulate protein phosphatase 2 pp2. His interests lie in the scientific and evolutionary as well as ethical, social and political implications of todays revolutions in the life sciences and in information. Additionally, signum biosciences has registered 7 trademarks with the most popular class being pharmaceutical, veterinary and sanitary products. It was founded in 2003 based on research done in the lab of jeffry b. Apr 27, 2010 if signum s research bears fruit, the near and longterm benefit to the alzheimers disease community will be significant.
Stock is cofounder of signum biosciences and my mercury risk inc. Gregory stock microsite celebrity speakers gregory. The merging of humans and machines into a global superorganism and author of redesigning humans. Facebook gives people the power to share and makes the world more open and connected. Currently he is the codirector of the mount sinai precision wellness center. Gregory stock, a biotech entrepreneur, academic scientist, bioethicist, bestselling author and public communicator is a leading authority on the broad impacts of genomic and advanced digitalhealth technologies.
He was the cofounder and ceo both of signum biosciences, a princetonbased biotechnology company developing therapeutics for alzheimers and other neurodegenerative diseases, and of ecoeos, an innovative genomics company offering genetic tests for susceptibility to. Gregory b stock phd signum biosciences, monmouth junction. He has broad scientific, media and business experience, holds an mba from harvard business school. Signum biosciences ceo and president, maxwell stock, has dedicated his life to translational. Max virtually grew up in the lab working with his father, dr. Signum biosciences is a private biotechnology company dedicated to developing smallmolecule therapeutics derived from its signal transduction modulation stm platform to modulate signal transduction imbalances. Originally published in 1987, the book of questions, a new york times bestseller, has been completely revised and updated to incorporate the myriad cultural shifts and hotbutton issues of the past twentyfive years, making it current and even more appealing. Join facebook to connect with gregory stock and others you may know. Gregory stock speakers bureau and booking agent info.
Jan 12, 2018 justia patents patents and patent application resources. Gregory stock the storefront genome from regenerative medicine to human design. He has written extensively on the implications for society, medicine and business of the human genome project and associated developments in molecular genetics. Gregory stock keynote speakers bureau and speaking fees. Celebrity appearance fees and availability contact a booking agent to check availability on dr. Sinai school of medicine in new york where he codirects the harris center for precision wellness and is working on. We develop cosmetic functional ingredients as well as topical drug candidates for dermatological disease.
Jeffry stock, and his nephew, maxwell stock, with the mission to bring better health, through novel products. This involves the synthesis of a novel chemical entity, and its subject approval by the fda as an investigatory new drug ind for the treatment of a specified. Nov 14, 2014 gregory stock, a biotech entrepreneur, bioethicist, bestselling author and public communicator is a leading authority on the broad impacts of genomic and other advanced technologies in the life. He has authored a number of books on the implications of new technology, particularly in the life sciences, and several. Jeffry stock, chairman of signum biosciences and professor of molecular biology and chemistry at princeton university. In 2004, stock cofounded signum biosciences, a princeton university. Gregory stock, stock s brother, served as the first ceo. He has written extensively on the implications for society, medicine and business of the human genome project and associated developments in molecular genetics and bioinformatics. Stock is a leading authority on the broad impacts of genomic and other advanced technologies in the life sciences. Gregory stock, a biotech entrepreneur, academic scientist, bioethicist, bestselling author and public communicator is a leading authority on the broad impacts of genomic and advanced. He founded the influential program on medicine, technology and society at uclas school of medicine in 1997 and served as its director. He has a phd in biophysics from johns hopkins and an mba from harvard. He also serves on the boards of signum biosciences, nutralogix, and napo pharmaceuticals, a private pharmaceutical company with a fasttracked drug for diarrhea associated with hiv retroviral therapy.
Signum biosciences names braham shroot as chief executive officer. Generated from over 30 years of princeton science, signum s novel platforms in neurology and dermatology are responsible for a core product line that was brought to market and sparked. His interests lie in the scientific and evolutionary as well as ethical, social and political implications of todays revolutions in the life sciences and in information technology and computers. Humans and machines into a global superorganism, the book of questions. The intellectual property of signum biosciences includes 12 registered patents primarily in the medical or veterinary science.
He founded the influential program on medicine, technology and society at. Stock has also worked as a business executive, and has been the chief executive officer of signum biosciences. Gregory stock is a biophysicist, bestselling author, biotech entrepreneur, and the former. Signum biosciences is a private biotechnology company dedicated to developing smallmolecule therapeutics to modulate. Gregory stock, a biotech entrepreneur, bioethicist, bestselling author and public communicator is a leading authority on the broad impacts of genomic and other advanced technologies in the life sciences. He was the cofounder and ceo both of signum biosciences, a princetonbased biotechnology company developing therapeutics for alzheimers and other neurodegenerative diseases, and of ecoeos, an innovative genomics company offering genetic. Speaker gregory stock genomics and biotech biotech. Gregory stock transhumanism wiki fandom powered by wikia. Gregory stock is a biophysicist, bestselling author, biotech entrepreneur, and the former director of the program on medicine, technology and society at ucla s school of medicine. Book gregory stock for speaking, events and appearances. Associate director at the center of life science studies at the university of californiaberkeley and chief executive officer of signum biosciences, a biotech company in princeton, new jersey. His interests lie in the scientific and evolutionary as well as ethical, social and political implications of todays revolutions in the life sciences and in. Gregory stock books list of books by author gregory stock.
He served as the ceo of signum for 6 years directing efforts there to develop promising pharma candidates for alzheimers and parkinsons. Gregory stock and other top corporate entertainment exclusive buyers agent that books celebrities, entertainers and speakers like dr. Gregory stocks long focus on the impact of new technologies and their relevance to. A read is counted each time someone views a publication summary such as the title, abstract, and list of authors, clicks on a figure, or views or downloads the fulltext. Stock directed the program on medicine, technology and society at uclas school of medicine.
Book gregory stock for speaking, events and appearances apb. He also is the ceo of signum biosciences, a biotech company developing. Chief executive officer maxwell stock comes from signum s parent company, signum biosciences, where he was a cofounder. Gregory stock for speaking engagements, appearances and corporate events. Gregory stock, a biotech entrepreneur, bioethicist, bestselling author and public communicator is a leading authority on the broad impacts of genomic and other advanced technologies in the life. Gregory stock keynote speakers, corporate entertainment. Gregory stock serves on the california advisory committee on stem cells and reproductive cloning. In 2003, he cofounded signum biosciences, a princeton university spinout. Market niche biotechnology positions niche sales business. To connect with gregory, sign up for facebook today. Gregory stock booking agent information speakers bureau assists companies seeking to hire speakers like dr. Gregory stock speaker agency, speaking fee, videos. Signum biosciences is a private biotechnology company dedicated to developing smallmolecule therapeutics.
Among other things, the present invention provides novel isoprenyl compounds capable of effectively modulating inflammatory responses and pharmaceutical, cosmetic, cosmeceutical and topical compositions comprising these isoprenyl compounds. Nov 11, 2019 the organizational chart of signum biosciences displays its 9 main executives including maxwell stock, eduardo perez and masanori tamura. Signum biosciences is a private biotechnology company dedicated to developing smallmolecule therapeutics derived from our phosphatase platform to modulate signal transduction imbalances. Signum biosciences is dedicated to producing conscious and natural products that target personalized health, while setting new standards for quality of life. See all books authored by gregory stock, including the book of questions, and the book of questions.
Gregory stock a best selling author and public speaker, has always been an advocate of health and wellness. Gregory stock, a biotech entrepreneur, academic scientist, bioethicist. Gregory stock is on the board of signum biosciences, inc. Through research on protein networks that control biological systems, signum is developing therapeutic agents for several skin conditions, alzheimers, parkinsons, asthma and copd. Jeffry stock at princeton university see figure below. In 2004, stock cofounded signum biosciences, a princeton university spinoff. Signum s phosphatase technology provides many opportunities for the development of novel pharmaceutical therapeutics. Stock is a strong advocate for aggressive biomedical funding and research, and for cautious governmental oversight.
961 557 332 204 804 510 119 1316 900 490 551 363 761 11 353 1484 325 687 1174 71 1448 416 1478 1481 961 1354 91 977 518 1143 265 453 371 950